01 1Zhejiang Huahai Pharmaceutical
01 1BRIVARACETAM
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-27
Pay. Date : 2022-10-14
DMF Number : 37524
Submission : 2022-09-26
Status : Active
Type : II
20
Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BRIVARACETAM, with a corresponding US DMF Number 37524.
Remarkably, this DMF maintains an Active status since its submission on September 26, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 27, 2022, and payment made on October 14, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
